Search

everythinglearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Biological therapy boosts the immune system to effectively fight melanoma.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Certain cancer drugs can cause skin issues like rashes and itching.

Cetuximab can cause unusual hair growth and hair loss.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Lack of TrkC receptor delays hair follicle development.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Activated β-catenin affects hair growth and skin thickness, and changes are reversible.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.